作者：郭雨剛a,b，李銳a,b，宋小平c，鐘永軍a,b，王晨光a,b，賈浩a,b，吳黎丹a,b，王棟a,b，方芳a,b，馬佳佳a,b，康文遙a,b，孫潔a,b，田志剛a,b，肖衛(wèi)華a,b
a：Hefei National Laboratory for Physical Sciences at Microscale, Innovation Center for Cell Biology, School of Life Sciences, University of Science and Technology of China
b：Center of Medical Biotechnology of Anhui Province, University of Science and Technology of China, Hefei, China
c：Department of Pharmacy, Anhui Medical College, Hefei, China
?
Abstract: CD83 is a highly glycosylated type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily. CD83 is upregulated during dendritic cell (DC) maturation, which is critical for the initiation of adaptive immune responses. The soluble isoform of CD83 (sCD83) is encoded by alternative splicing from full-length CD83 mRNA and inhibits DC maturation, which suggests that sCD83 acts as a potential immune suppressor. In this study, we developed a sound strategy to express functional sCD83 from Pichia pastoris in extremely high-density fermentation. Purified sCD83 was expressed as a monomer at a yield of more than 200 mg/L and contained N-linked glycosylation sites that were characterized by PNGase F digestion. In vitro tests indicated that recombinant sCD83 bound to its putative counterpart on monocytes and specifically blocked the binding of anti-CD83 antibodies to cell surface CD83 on DCs. Moreover, sCD83 from yeast suppressed lymphocyte proliferation in a dose-dependent manner. Therefore, sCD83 that was expressed from the P. pastoris was functionally active and may be used for in vivo and in vitro studies as well as future clinical applications.
?
URL: http://dx.plos.org/10.1371/journal.pone.0089264
?
版權與免責聲明：本網頁的內容由收集互聯網上公開發(fā)布的信息整理獲得。目的在于傳遞信息及分享，并不意味著贊同其觀點或證實其真實性，也不構成其他建議。僅提供交流平臺，不為其版權負責。如涉及侵權，請聯系我們及時修改或刪除。郵箱：sales@allpeptide.com